This research hub will further strengthen Canada’s biomanufacturing and life sciences sector while protecting Canadians against future health threats
Toronto – The Government of Canada’s main priority continues to be protecting the health and safety of Canadians. Throughout the pandemic, the quick and decisive actions taken by the government meant that Canada was able to scale up domestic biomanufacturing capacity, which had been in decline for over 40 years. The government is rebuilding a strong and competitive biomanufacturing and life sciences sector brick by brick. This includes strengthening the foundations of the life sciences ecosystem through the research and talent of Canada’s world-class post-secondary institutions and research hospitals, as well as fostering increased collaboration with innovative companies.
Adam van Koeverden, Parliamentary Secretary to the Minister of Health and to the Minister of Sport, highlighted an investment of $2 million to create the Canadian Hub for Health Intelligence & Innovation in Infectious Diseases. This support is part of a $10 million investment announced by François-Philippe Champagne, Minister of Innovation, Science and Industry, and Jean-Yves Duclos, Minister of Health, on March 2 for the creation of five research hubs as part of Stage 1 of the integrated Canada Biomedical Research Fund (CBRF) and Biosciences Research Infrastructure Fund (BRIF) competition.
The Canadian Hub for Health Intelligence & Innovation in Infectious Diseases is being led by the University of Toronto. Its focus will be on advancing the concept of “personalized and precise medicine” to influence the development of vaccines, therapeutics and other public health interventions. This multidisciplinary research hub will accelerate research and development of next-generation vaccines, therapeutics and diagnostics, while supporting training and development to expand the pipeline of skilled talent. It will also accelerate the translation of promising research into commercially viable products and processes.
This investment will help strengthen the resilience of Canada’s life sciences sector by supporting leading Canadian research in innovative technologies that keep us safe and boost our economy.
“To continue to protect Canadians and to build a resilient biomanufacturing ecosystem, our government is taking every action possible to be equipped with the best tools. We’re proud to foster the research needed to produce cutting-edge discoveries and products in our very own labs, which will help us build a stronger, more robust life sciences sector that responds to the needs of Canadians for decades to come.” – François-Philippe Champagne, Minister of Innovation, Science and Industry